Crutcher Madison, Seidler Paul M
Department of Pharmacology and Pharmaceutical Sciences, University of Southern California School of Pharmacy, 1985 Zonal Ave., Los Angeles, CA 90089-9121, USA.
Vaccines (Basel). 2021 Oct 22;9(11):1229. doi: 10.3390/vaccines9111229.
Two of the three COVID-19 vaccines approved in the United States require two doses to reach full efficacy, as do others available elsewhere in the world. The complete series of multidose COVID-19 vaccines offers stronger protection against infection by SARS-CoV-2 compared to single-dose injections with the same vaccines. Achieving perfect community-level adherence is a challenge in any public health campaign, even in non-pandemic times. Vaccines requiring multiple doses combined with a surge of vaccine hesitancy and misinformation that has been witnessed by the public during the COVID-19 pandemic are exacerbating the challenge of ensuring the world's population achieves a sufficient level of immunity against COVID-19. Here, we describe the results of our study in which we sought to determine whether completion of a two-dose COVID-19 vaccine regimen could be improved by disseminating infographics that explain what the vaccine is and why returning for the second dose is beneficial. Our results show that the proportion of COVID-19 vaccine recipients returning for a second inoculation grew after COVID-19 vaccine infographics were distributed to first-time vaccine recipients. We suggest that extending communication and outreach initiatives into the clinic positively influences the rate of follow-up visits, and that infographics are useful tools to aid and bolster the deployment of COVID-19 vaccines.
美国批准的三种新冠疫苗中有两种需要接种两剂才能达到完全效力,世界其他地方可用的其他疫苗也是如此。与使用相同疫苗的单剂量注射相比,完整系列的多剂量新冠疫苗对SARS-CoV-2感染提供更强的保护。在任何公共卫生运动中,即使在非大流行时期,实现完美的社区层面依从性都是一项挑战。在新冠大流行期间,公众目睹了需要多剂接种的疫苗与疫苗犹豫和错误信息激增的情况,这加剧了确保世界人口获得足够水平的新冠免疫力的挑战。在此,我们描述了我们的研究结果,我们试图确定通过传播解释疫苗是什么以及为什么返回接种第二剂有益的信息图表,是否可以提高两剂新冠疫苗接种方案的完成率。我们的结果表明,在向首次接种疫苗的人群分发新冠疫苗信息图表后,返回接种第二剂的新冠疫苗接种者比例有所增加。我们建议将沟通和推广举措扩展到诊所对后续就诊率有积极影响,并且信息图表是有助于并支持新冠疫苗接种的有用工具。